Arrow-right Camera
The Spokesman-Review Newspaper
Spokane, Washington  Est. May 19, 1883

Osteoporosis Drug A Milestone

Los Angeles Times

The Food and Drug Administration Monday approved the first nonhormonal drug to treat osteoporosis, a progressive and often crippling bone disease that may afflict as many as 25 million Americans.

The approval offers the first drug alternative to hormone replacement therapy for post-menopausal women, who are particularly susceptible to the condition.

Hormones have been associated with an increased risk of cancer of the breast and uterus.